These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 38350291

  • 1. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder.
    Parmenter ME, Lederman S, Weathers FW, Davis LL, Vaughn B, Engels J, Sullivan GM.
    Psychiatry Res; 2024 Apr; 334():115764. PubMed ID: 38350291
    [Abstract] [Full Text] [Related]

  • 2. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response.
    Sullivan GM, Gendreau RM, Gendreau J, Peters P, Peters A, Engels J, Daugherty BL, Vaughn B, Weathers FW, Lederman S.
    Psychiatry Res; 2021 Jul; 301():113974. PubMed ID: 33979763
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial.
    Lederman S, Arnold LM, Vaughn B, Kelley M, Sullivan GM.
    Arthritis Care Res (Hoboken); 2023 Nov; 75(11):2359-2368. PubMed ID: 37165930
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.
    JAMA; 2000 Apr 12; 283(14):1837-44. PubMed ID: 10770145
    [Abstract] [Full Text] [Related]

  • 5. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
    Krystal JH, Pietrzak RH, Rosenheck RA, Cramer JA, Vessicchio J, Jones KM, Huang GD, Vertrees JE, Collins J, Krystal AD, Veterans Affairs Cooperative Study #504 Group.
    J Clin Psychiatry; 2016 Apr 12; 77(4):483-91. PubMed ID: 26890894
    [Abstract] [Full Text] [Related]

  • 6. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Verplaetse TL, Ralevski E, Roberts W, Gueorguieva R, McKee SA, Petrakis IL.
    Alcohol Clin Exp Res; 2019 Apr 12; 43(4):741-746. PubMed ID: 30698839
    [Abstract] [Full Text] [Related]

  • 7. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F, Raskind MA.
    J Clin Psychopharmacol; 2002 Feb 12; 22(1):82-5. PubMed ID: 11799347
    [Abstract] [Full Text] [Related]

  • 8. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT, West JC, Dempsey CL, Possemato K, Bartolanzo D, Aliaga P, Zarate C, Vythilingam M, Benedek DM.
    J Clin Psychiatry; 2020 Oct 27; 81(6):. PubMed ID: 33113596
    [Abstract] [Full Text] [Related]

  • 9. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, Hart KL, McFall M, Mellman TA, Reist C, Romesser J, Rosenheck R, Shih MC, Stein MB, Swift R, Gleason T, Lu Y, Huang GD.
    N Engl J Med; 2018 Feb 08; 378(6):507-517. PubMed ID: 29414272
    [Abstract] [Full Text] [Related]

  • 10. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD.
    J Clin Psychiatry; 2001 Nov 08; 62(11):860-8. PubMed ID: 11775045
    [Abstract] [Full Text] [Related]

  • 11. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
    Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, Dobie DJ, Hoff D, Rein RJ, Straits-Tröster K, Thomas RG, McFall MM.
    Am J Psychiatry; 2003 Feb 08; 160(2):371-3. PubMed ID: 12562588
    [Abstract] [Full Text] [Related]

  • 12. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM.
    J Clin Psychiatry; 2011 Jul 08; 72(7):892-7. PubMed ID: 21367352
    [Abstract] [Full Text] [Related]

  • 13. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.
    J Clin Psychiatry; 2006 Oct 08; 67(10):1522-6. PubMed ID: 17107242
    [Abstract] [Full Text] [Related]

  • 14. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.
    J Clin Psychiatry; 2008 Apr 08; 69(4):520-5. PubMed ID: 18278987
    [Abstract] [Full Text] [Related]

  • 15. Bright Light Treatment of Combat-related PTSD: A Randomized Controlled Trial.
    Youngstedt SD, Kline CE, Reynolds AM, Crowley SK, Burch JB, Khan N, Han S.
    Mil Med; 2022 Mar 28; 187(3-4):e435-e444. PubMed ID: 33511988
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.
    J Clin Psychiatry; 2002 Mar 28; 63(3):199-206. PubMed ID: 11926718
    [Abstract] [Full Text] [Related]

  • 17. Self-reported sleep problems in active-duty US Army personnel receiving posttraumatic stress disorder treatment in group or individual formats: secondary analysis of a randomized clinical trial.
    Pruiksma KE, Taylor DJ, Wachen JS, Straud CL, Hale WJ, Mintz J, Young-McCaughan S, Peterson AL, Yarvis JS, Borah EV, Dondanville KA, Litz BT, Resick PA.
    J Clin Sleep Med; 2023 Aug 01; 19(8):1389-1398. PubMed ID: 36988304
    [Abstract] [Full Text] [Related]

  • 18. Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial.
    Zohar J, Fostick L, Juven-Wetzler A, Kaplan Z, Shalev H, Schreiber G, Miroshnik N, Shalev AY, Stein DJ, Seedat S, Suliman S, Klein E.
    J Clin Psychiatry; 2018 Aug 01; 79(2):. PubMed ID: 28703951
    [Abstract] [Full Text] [Related]

  • 19. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.
    Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF.
    J Clin Psychiatry; 2016 May 01; 77(5):e561-5. PubMed ID: 27249080
    [Abstract] [Full Text] [Related]

  • 20. Randomized, Placebo-Controlled Trial of the Angiotensin Receptor Antagonist Losartan for Posttraumatic Stress Disorder.
    Stein MB, Jain S, Simon NM, West JC, Marvar PJ, Bui E, He F, Benedek DM, Cassano P, Griffith JL, Howlett J, Malgaroli M, Melaragno A, Seligowski AV, Shu IW, Song S, Szuhany K, Taylor CT, Ressler KJ, LOSe-PTSD Investigators.
    Biol Psychiatry; 2021 Oct 01; 90(7):473-481. PubMed ID: 34275593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.